These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2878714

  • 1. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
    Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NP, Gauthier S.
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):503-10. PubMed ID: 2878714
    [Abstract] [Full Text] [Related]

  • 2. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P, Katzman R, Terry RD.
    Nature; 1980 Nov 20; 288(5788):279-80. PubMed ID: 6107862
    [Abstract] [Full Text] [Related]

  • 3. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R.
    J Neurochem; 1988 Jun 20; 50(6):1914-23. PubMed ID: 3373218
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neurotransmitters in dementia.
    Nakamura S, Koshimura K, Kato T, Yamao S, Iijima S, Nagata H, Miyata S, Fujiyoshi K, Okamoto K, Suga H.
    Clin Ther; 1984 Jun 20; 7 Spec No():18-34. PubMed ID: 6152197
    [Abstract] [Full Text] [Related]

  • 6. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL.
    Neurosci Lett; 1980 Dec 20; 20(3):373-7. PubMed ID: 6108540
    [Abstract] [Full Text] [Related]

  • 7. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).
    Gottfries CG, Adolfsson R, Aquilonius SM, Carlsson A, Eckernäs SA, Nordberg A, Oreland L, Svennerholm L, Wiberg A, Winblad B.
    Neurobiol Aging; 1983 Dec 20; 4(4):261-71. PubMed ID: 6200784
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT, Penney JB, Young AB, D'Amato CJ, Hicks SP, Shoulson I.
    Science; 1985 Mar 22; 227(4693):1496-9. PubMed ID: 2858129
    [Abstract] [Full Text] [Related]

  • 14. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease.
    Ichai C, Chevallier N, Delaere P, Dournaud P, Epelbaum J, Hauw JJ, Vincent JP, Checler F.
    J Neurochem; 1994 Feb 22; 62(2):645-55. PubMed ID: 7905027
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S, Taniguchi T, Fujiwara M, Kameyama M.
    J Neurochem; 1986 Jan 22; 46(1):288-93. PubMed ID: 3940287
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.